BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24509896)

  • 1. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity.
    Salaffi F; De Angelis R; Carotti M; Gutierrez M; Sarzi-Puttini P; Atzeni F
    Rheumatol Int; 2014 Aug; 34(8):1103-10. PubMed ID: 24509896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
    Wach J; Letroublon MC; Coury F; Tebib JG
    J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
    Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
    Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
    Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis.
    Gao R
    J Musculoskelet Neuronal Interact; 2021 Sep; 21(3):440-446. PubMed ID: 34465685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study.
    Benavent D; Capelusnik D; Ramiro S; Molto A; López-Medina C; Dougados M; Navarro-Compán V
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36096523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromyalgia in women with ankylosing spondylitis.
    Aloush V; Ablin JN; Reitblat T; Caspi D; Elkayam O
    Rheumatol Int; 2007 Jul; 27(9):865-8. PubMed ID: 17476510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.
    Kılıç G; Kılıç E; Nas K; Karkucak M; Çapkın E; Dağlı AZ; Çevik R; Özgöçmen S
    Clin Rheumatol; 2015 Mar; 34(3):515-21. PubMed ID: 24985042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis.
    Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM
    Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Fibromyalgia Syndrome and Its Relationship with Clinical Parameters in Patients with Axial Spondyloarthritis.
    Rencber N; Saglam G; Huner B; Kuru O
    Pain Physician; 2019 Nov; 22(6):E579-E585. PubMed ID: 31775411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
    Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA
    Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.
    Monti S; Todoerti M; Codullo V; Favalli EG; Biggioggero M; Becciolini A; Montecucco C; Caporali R
    Mod Rheumatol; 2018 May; 28(3):542-549. PubMed ID: 28880727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).
    Solmaz D; Yildirim T; Avci O; Tomas N; Akar S
    Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level.
    Baraka E; Balata M; Ahmed S; El-Blbehisy M; Elattar E
    Curr Rheumatol Rev; 2021; 17(3):331-341. PubMed ID: 33459239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies.
    Sayın S; Yurdakul FG; Sivas F; Bodur H
    Rheumatol Int; 2020 Nov; 40(11):1835-1841. PubMed ID: 32767083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.